nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ABCB1—ovarian cancer	0.221	1	CbGaD
Liotrix—SLCO1A2—Chlorambucil—ovarian cancer	0.182	0.381	CbGbCtD
Liotrix—SLCO1B3—Paclitaxel—ovarian cancer	0.101	0.212	CbGbCtD
Liotrix—SLCO1B3—Docetaxel—ovarian cancer	0.0733	0.153	CbGbCtD
Liotrix—ABCB1—Topotecan—ovarian cancer	0.0342	0.0714	CbGbCtD
Liotrix—CYP2C8—Paclitaxel—ovarian cancer	0.025	0.0522	CbGbCtD
Liotrix—ABCB1—Vinorelbine—ovarian cancer	0.0241	0.0503	CbGbCtD
Liotrix—ABCB1—Paclitaxel—ovarian cancer	0.0169	0.0353	CbGbCtD
Liotrix—ABCB1—Docetaxel—ovarian cancer	0.0122	0.0256	CbGbCtD
Liotrix—ABCB1—Doxorubicin—ovarian cancer	0.00911	0.019	CbGbCtD
Liotrix—SLC16A2—myometrium—ovarian cancer	0.00266	0.0353	CbGeAlD
Liotrix—SERPINA7—bone marrow—ovarian cancer	0.00262	0.0347	CbGeAlD
Liotrix—SLCO4C1—endometrium—ovarian cancer	0.00215	0.0286	CbGeAlD
Liotrix—TTR—embryo—ovarian cancer	0.0021	0.0279	CbGeAlD
Liotrix—SLC16A2—uterine cervix—ovarian cancer	0.00207	0.0275	CbGeAlD
Liotrix—SLCO4A1—myometrium—ovarian cancer	0.00196	0.026	CbGeAlD
Liotrix—THRB—gonad—ovarian cancer	0.00192	0.0254	CbGeAlD
Liotrix—THRA—gonad—ovarian cancer	0.00192	0.0254	CbGeAlD
Liotrix—SLC16A2—endometrium—ovarian cancer	0.00187	0.0249	CbGeAlD
Liotrix—SLC16A2—uterus—ovarian cancer	0.00172	0.0229	CbGeAlD
Liotrix—THRB—female reproductive system—ovarian cancer	0.00171	0.0227	CbGeAlD
Liotrix—THRA—female reproductive system—ovarian cancer	0.00171	0.0227	CbGeAlD
Liotrix—SLC10A1—gonad—ovarian cancer	0.00169	0.0225	CbGeAlD
Liotrix—SLCO4C1—bone marrow—ovarian cancer	0.00169	0.0224	CbGeAlD
Liotrix—SLCO4C1—vagina—ovarian cancer	0.00161	0.0214	CbGeAlD
Liotrix—SLCO1B3—vagina—ovarian cancer	0.00157	0.0208	CbGeAlD
Liotrix—THRB—female gonad—ovarian cancer	0.00156	0.0207	CbGeAlD
Liotrix—THRA—female gonad—ovarian cancer	0.00156	0.0207	CbGeAlD
Liotrix—THRB—vagina—ovarian cancer	0.00155	0.0206	CbGeAlD
Liotrix—SLC10A1—female reproductive system—ovarian cancer	0.00151	0.0201	CbGeAlD
Liotrix—SLCO4A1—decidua—ovarian cancer	0.00145	0.0193	CbGeAlD
Liotrix—SLC16A2—female gonad—ovarian cancer	0.00141	0.0187	CbGeAlD
Liotrix—SLC16A2—vagina—ovarian cancer	0.0014	0.0186	CbGeAlD
Liotrix—THRA—testis—ovarian cancer	0.00138	0.0183	CbGeAlD
Liotrix—THRB—testis—ovarian cancer	0.00138	0.0183	CbGeAlD
Liotrix—SLCO4A1—endometrium—ovarian cancer	0.00138	0.0183	CbGeAlD
Liotrix—SLC16A10—epithelium—ovarian cancer	0.00135	0.0179	CbGeAlD
Liotrix—TTR—female reproductive system—ovarian cancer	0.00127	0.0169	CbGeAlD
Liotrix—SLC16A2—testis—ovarian cancer	0.00125	0.0166	CbGeAlD
Liotrix—SLC10A1—testis—ovarian cancer	0.00122	0.0162	CbGeAlD
Liotrix—TTR—bone marrow—ovarian cancer	0.0012	0.0159	CbGeAlD
Liotrix—SLCO1C1—testis—ovarian cancer	0.00115	0.0152	CbGeAlD
Liotrix—SLCO4A1—female reproductive system—ovarian cancer	0.00114	0.0151	CbGeAlD
Liotrix—SLC16A10—gonad—ovarian cancer	0.00112	0.0149	CbGeAlD
Liotrix—SLCO4A1—vagina—ovarian cancer	0.00103	0.0137	CbGeAlD
Liotrix—TTR—testis—ovarian cancer	0.00103	0.0136	CbGeAlD
Liotrix—SLCO1B1—female reproductive system—ovarian cancer	0.001	0.0133	CbGeAlD
Liotrix—THRB—lymph node—ovarian cancer	0.001	0.0133	CbGeAlD
Liotrix—THRA—lymph node—ovarian cancer	0.001	0.0133	CbGeAlD
Liotrix—SLC16A10—female reproductive system—ovarian cancer	0.001	0.0133	CbGeAlD
Liotrix—SLCO4A1—testis—ovarian cancer	0.00092	0.0122	CbGeAlD
Liotrix—SLC16A2—lymph node—ovarian cancer	0.000907	0.012	CbGeAlD
Liotrix—SLC16A10—vagina—ovarian cancer	0.000904	0.012	CbGeAlD
Liotrix—SLCO1C1—lymph node—ovarian cancer	0.000832	0.0111	CbGeAlD
Liotrix—SLC16A10—testis—ovarian cancer	0.000807	0.0107	CbGeAlD
Liotrix—CYP2C8—endometrium—ovarian cancer	0.000689	0.00914	CbGeAlD
Liotrix—SLCO4A1—lymph node—ovarian cancer	0.000667	0.00886	CbGeAlD
Liotrix—SLCO1A2—testis—ovarian cancer	0.000659	0.00875	CbGeAlD
Liotrix—ALB—testis—ovarian cancer	0.000655	0.0087	CbGeAlD
Liotrix—SLC16A10—lymph node—ovarian cancer	0.000585	0.00777	CbGeAlD
Liotrix—CYP2C8—female reproductive system—ovarian cancer	0.00057	0.00758	CbGeAlD
Liotrix—CYP2C8—vagina—ovarian cancer	0.000516	0.00685	CbGeAlD
Liotrix—ALB—lymph node—ovarian cancer	0.000475	0.00631	CbGeAlD
Liotrix—ABCB1—myometrium—ovarian cancer	0.000469	0.00623	CbGeAlD
Liotrix—CYP2C8—testis—ovarian cancer	0.00046	0.00611	CbGeAlD
Liotrix—ABCB1—embryo—ovarian cancer	0.000451	0.00599	CbGeAlD
Liotrix—Levothyroxine—ABCB1—ovarian cancer	0.000384	0.584	CrCbGaD
Liotrix—ABCB1—epithelium—ovarian cancer	0.000368	0.00489	CbGeAlD
Liotrix—ABCB1—uterine cervix—ovarian cancer	0.000365	0.00485	CbGeAlD
Liotrix—ABCB1—decidua—ovarian cancer	0.000348	0.00462	CbGeAlD
Liotrix—ABCB1—endometrium—ovarian cancer	0.00033	0.00438	CbGeAlD
Liotrix—ABCB1—gonad—ovarian cancer	0.000306	0.00407	CbGeAlD
Liotrix—ABCB1—uterus—ovarian cancer	0.000304	0.00404	CbGeAlD
Liotrix—Liothyronine—ABCB1—ovarian cancer	0.000274	0.416	CrCbGaD
Liotrix—ABCB1—female reproductive system—ovarian cancer	0.000274	0.00363	CbGeAlD
Liotrix—ABCB1—bone marrow—ovarian cancer	0.000258	0.00343	CbGeAlD
Liotrix—ABCB1—female gonad—ovarian cancer	0.000249	0.0033	CbGeAlD
Liotrix—ABCB1—vagina—ovarian cancer	0.000247	0.00328	CbGeAlD
Liotrix—Pruritus—Melphalan—ovarian cancer	0.000246	0.00142	CcSEcCtD
Liotrix—Tension—Paclitaxel—ovarian cancer	0.000245	0.00142	CcSEcCtD
Liotrix—Dysgeusia—Paclitaxel—ovarian cancer	0.000245	0.00142	CcSEcCtD
Liotrix—Hypoglycaemia—Epirubicin—ovarian cancer	0.000243	0.00141	CcSEcCtD
Liotrix—Cardiac failure—Epirubicin—ovarian cancer	0.000243	0.00141	CcSEcCtD
Liotrix—Nervousness—Paclitaxel—ovarian cancer	0.000243	0.00141	CcSEcCtD
Liotrix—Diarrhoea—Topotecan—ovarian cancer	0.000243	0.00141	CcSEcCtD
Liotrix—Hypoaesthesia—Docetaxel—ovarian cancer	0.000242	0.0014	CcSEcCtD
Liotrix—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000242	0.0014	CcSEcCtD
Liotrix—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000242	0.0014	CcSEcCtD
Liotrix—Urticaria—Vinorelbine—ovarian cancer	0.000241	0.0014	CcSEcCtD
Liotrix—Body temperature increased—Vinorelbine—ovarian cancer	0.00024	0.00139	CcSEcCtD
Liotrix—Abdominal pain—Vinorelbine—ovarian cancer	0.00024	0.00139	CcSEcCtD
Liotrix—Renal failure acute—Doxorubicin—ovarian cancer	0.000238	0.00138	CcSEcCtD
Liotrix—Diarrhoea—Melphalan—ovarian cancer	0.000238	0.00138	CcSEcCtD
Liotrix—Nausea—Chlorambucil—ovarian cancer	0.000237	0.00137	CcSEcCtD
Liotrix—Vision blurred—Paclitaxel—ovarian cancer	0.000236	0.00137	CcSEcCtD
Liotrix—Dizziness—Topotecan—ovarian cancer	0.000234	0.00136	CcSEcCtD
Liotrix—Tremor—Paclitaxel—ovarian cancer	0.000234	0.00136	CcSEcCtD
Liotrix—Increased appetite—Doxorubicin—ovarian cancer	0.000234	0.00135	CcSEcCtD
Liotrix—Affect lability—Epirubicin—ovarian cancer	0.000234	0.00135	CcSEcCtD
Liotrix—Renal impairment—Doxorubicin—ovarian cancer	0.000231	0.00134	CcSEcCtD
Liotrix—Agitation—Paclitaxel—ovarian cancer	0.00023	0.00133	CcSEcCtD
Liotrix—Angioedema—Paclitaxel—ovarian cancer	0.000228	0.00132	CcSEcCtD
Liotrix—Flushing—Docetaxel—ovarian cancer	0.000226	0.00131	CcSEcCtD
Liotrix—Cardiac arrest—Epirubicin—ovarian cancer	0.000226	0.00131	CcSEcCtD
Liotrix—Vomiting—Topotecan—ovarian cancer	0.000225	0.00131	CcSEcCtD
Liotrix—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000225	0.0013	CcSEcCtD
Liotrix—Cardiac failure—Doxorubicin—ovarian cancer	0.000225	0.0013	CcSEcCtD
Liotrix—Mood swings—Epirubicin—ovarian cancer	0.000225	0.0013	CcSEcCtD
Liotrix—Syncope—Paclitaxel—ovarian cancer	0.000224	0.0013	CcSEcCtD
Liotrix—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000224	0.0013	CcSEcCtD
Liotrix—Rash—Topotecan—ovarian cancer	0.000224	0.0013	CcSEcCtD
Liotrix—Hypersensitivity—Vinorelbine—ovarian cancer	0.000223	0.0013	CcSEcCtD
Liotrix—Dermatitis—Topotecan—ovarian cancer	0.000223	0.00129	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—ovarian cancer	0.000222	0.00129	CcSEcCtD
Liotrix—Headache—Topotecan—ovarian cancer	0.000222	0.00129	CcSEcCtD
Liotrix—Palpitations—Paclitaxel—ovarian cancer	0.000221	0.00128	CcSEcCtD
Liotrix—ABCB1—testis—ovarian cancer	0.000221	0.00293	CbGeAlD
Liotrix—Vomiting—Melphalan—ovarian cancer	0.000221	0.00128	CcSEcCtD
Liotrix—Dehydration—Epirubicin—ovarian cancer	0.000221	0.00128	CcSEcCtD
Liotrix—Loss of consciousness—Paclitaxel—ovarian cancer	0.00022	0.00127	CcSEcCtD
Liotrix—Rash—Melphalan—ovarian cancer	0.000219	0.00127	CcSEcCtD
Liotrix—Dermatitis—Melphalan—ovarian cancer	0.000219	0.00127	CcSEcCtD
Liotrix—Asthenia—Vinorelbine—ovarian cancer	0.000218	0.00126	CcSEcCtD
Liotrix—Arrhythmia—Docetaxel—ovarian cancer	0.000217	0.00126	CcSEcCtD
Liotrix—Convulsion—Paclitaxel—ovarian cancer	0.000217	0.00126	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—ovarian cancer	0.000216	0.00125	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—ovarian cancer	0.000216	0.00125	CcSEcCtD
Liotrix—Hypertension—Paclitaxel—ovarian cancer	0.000216	0.00125	CcSEcCtD
Liotrix—Alopecia—Docetaxel—ovarian cancer	0.000215	0.00125	CcSEcCtD
Liotrix—Pruritus—Vinorelbine—ovarian cancer	0.000215	0.00124	CcSEcCtD
Liotrix—Chest pain—Paclitaxel—ovarian cancer	0.000213	0.00123	CcSEcCtD
Liotrix—Arthralgia—Paclitaxel—ovarian cancer	0.000213	0.00123	CcSEcCtD
Liotrix—Anxiety—Paclitaxel—ovarian cancer	0.000212	0.00123	CcSEcCtD
Liotrix—Nausea—Topotecan—ovarian cancer	0.000211	0.00122	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—ovarian cancer	0.000209	0.00121	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—ovarian cancer	0.000209	0.00121	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—ovarian cancer	0.000208	0.00121	CcSEcCtD
Liotrix—Diarrhoea—Vinorelbine—ovarian cancer	0.000207	0.0012	CcSEcCtD
Liotrix—Dysgeusia—Docetaxel—ovarian cancer	0.000207	0.0012	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—ovarian cancer	0.000206	0.0012	CcSEcCtD
Liotrix—Nausea—Melphalan—ovarian cancer	0.000206	0.0012	CcSEcCtD
Liotrix—Confusional state—Paclitaxel—ovarian cancer	0.000206	0.00119	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000206	0.00119	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—ovarian cancer	0.000205	0.00119	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—ovarian cancer	0.000204	0.00118	CcSEcCtD
Liotrix—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000204	0.00118	CcSEcCtD
Liotrix—Oedema—Paclitaxel—ovarian cancer	0.000204	0.00118	CcSEcCtD
Liotrix—Infection—Paclitaxel—ovarian cancer	0.000203	0.00118	CcSEcCtD
Liotrix—Shock—Paclitaxel—ovarian cancer	0.000201	0.00116	CcSEcCtD
Liotrix—Dizziness—Vinorelbine—ovarian cancer	0.000201	0.00116	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—ovarian cancer	0.0002	0.00116	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—ovarian cancer	0.0002	0.00116	CcSEcCtD
Liotrix—Tachycardia—Paclitaxel—ovarian cancer	0.000199	0.00115	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—ovarian cancer	0.000197	0.00114	CcSEcCtD
Liotrix—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000197	0.00114	CcSEcCtD
Liotrix—Anorexia—Paclitaxel—ovarian cancer	0.000194	0.00113	CcSEcCtD
Liotrix—Muscular weakness—Doxorubicin—ovarian cancer	0.000194	0.00112	CcSEcCtD
Liotrix—Vomiting—Vinorelbine—ovarian cancer	0.000193	0.00112	CcSEcCtD
Liotrix—Rash—Vinorelbine—ovarian cancer	0.000191	0.00111	CcSEcCtD
Liotrix—Dermatitis—Vinorelbine—ovarian cancer	0.000191	0.00111	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—ovarian cancer	0.000191	0.00111	CcSEcCtD
Liotrix—Hypotension—Paclitaxel—ovarian cancer	0.000191	0.00111	CcSEcCtD
Liotrix—Headache—Vinorelbine—ovarian cancer	0.00019	0.0011	CcSEcCtD
Liotrix—Syncope—Docetaxel—ovarian cancer	0.00019	0.0011	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—ovarian cancer	0.00019	0.0011	CcSEcCtD
Liotrix—Palpitations—Docetaxel—ovarian cancer	0.000187	0.00109	CcSEcCtD
Liotrix—Loss of consciousness—Docetaxel—ovarian cancer	0.000186	0.00108	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000186	0.00108	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—ovarian cancer	0.000186	0.00108	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—ovarian cancer	0.000185	0.00107	CcSEcCtD
Liotrix—Insomnia—Paclitaxel—ovarian cancer	0.000184	0.00107	CcSEcCtD
Liotrix—Convulsion—Docetaxel—ovarian cancer	0.000184	0.00106	CcSEcCtD
Liotrix—Paraesthesia—Paclitaxel—ovarian cancer	0.000183	0.00106	CcSEcCtD
Liotrix—Hypertension—Docetaxel—ovarian cancer	0.000183	0.00106	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—ovarian cancer	0.000182	0.00106	CcSEcCtD
Liotrix—Dyspnoea—Paclitaxel—ovarian cancer	0.000182	0.00105	CcSEcCtD
Liotrix—Arthralgia—Docetaxel—ovarian cancer	0.00018	0.00105	CcSEcCtD
Liotrix—Chest pain—Docetaxel—ovarian cancer	0.00018	0.00105	CcSEcCtD
Liotrix—Nausea—Vinorelbine—ovarian cancer	0.00018	0.00104	CcSEcCtD
Liotrix—Renal failure—Epirubicin—ovarian cancer	0.00018	0.00104	CcSEcCtD
Liotrix—Decreased appetite—Paclitaxel—ovarian cancer	0.000177	0.00103	CcSEcCtD
Liotrix—Fatigue—Paclitaxel—ovarian cancer	0.000176	0.00102	CcSEcCtD
Liotrix—Sweating—Epirubicin—ovarian cancer	0.000175	0.00102	CcSEcCtD
Liotrix—Constipation—Paclitaxel—ovarian cancer	0.000174	0.00101	CcSEcCtD
Liotrix—Confusional state—Docetaxel—ovarian cancer	0.000174	0.00101	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—ovarian cancer	0.000173	0.001	CcSEcCtD
Liotrix—Oedema—Docetaxel—ovarian cancer	0.000173	0.001	CcSEcCtD
Liotrix—Infection—Docetaxel—ovarian cancer	0.000172	0.000996	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—ovarian cancer	0.000172	0.000995	CcSEcCtD
Liotrix—Shock—Docetaxel—ovarian cancer	0.00017	0.000986	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—ovarian cancer	0.000169	0.000978	CcSEcCtD
Liotrix—Feeling abnormal—Paclitaxel—ovarian cancer	0.000168	0.000975	CcSEcCtD
Liotrix—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000167	0.000967	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—ovarian cancer	0.000166	0.000964	CcSEcCtD
Liotrix—Anorexia—Docetaxel—ovarian cancer	0.000165	0.000956	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—ovarian cancer	0.000163	0.000947	CcSEcCtD
Liotrix—Sweating—Doxorubicin—ovarian cancer	0.000162	0.00094	CcSEcCtD
Liotrix—Urticaria—Paclitaxel—ovarian cancer	0.000162	0.00094	CcSEcCtD
Liotrix—Hypotension—Docetaxel—ovarian cancer	0.000162	0.000937	CcSEcCtD
Liotrix—Abdominal pain—Paclitaxel—ovarian cancer	0.000161	0.000935	CcSEcCtD
Liotrix—Body temperature increased—Paclitaxel—ovarian cancer	0.000161	0.000935	CcSEcCtD
Liotrix—ABCB1—lymph node—ovarian cancer	0.00016	0.00212	CbGeAlD
Liotrix—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000158	0.000913	CcSEcCtD
Liotrix—Insomnia—Docetaxel—ovarian cancer	0.000156	0.000907	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—ovarian cancer	0.000155	0.0009	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—ovarian cancer	0.000154	0.000894	CcSEcCtD
Liotrix—Flushing—Epirubicin—ovarian cancer	0.000152	0.000883	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000151	0.000876	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—ovarian cancer	0.00015	0.000871	CcSEcCtD
Liotrix—Hypersensitivity—Paclitaxel—ovarian cancer	0.00015	0.000871	CcSEcCtD
Liotrix—Fatigue—Docetaxel—ovarian cancer	0.000149	0.000864	CcSEcCtD
Liotrix—Constipation—Docetaxel—ovarian cancer	0.000148	0.000857	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—ovarian cancer	0.000147	0.00085	CcSEcCtD
Liotrix—Asthenia—Paclitaxel—ovarian cancer	0.000146	0.000849	CcSEcCtD
Liotrix—Alopecia—Epirubicin—ovarian cancer	0.000145	0.000841	CcSEcCtD
Liotrix—Pruritus—Paclitaxel—ovarian cancer	0.000144	0.000837	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—ovarian cancer	0.000142	0.000826	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000141	0.00082	CcSEcCtD
Liotrix—Flushing—Doxorubicin—ovarian cancer	0.000141	0.000817	CcSEcCtD
Liotrix—Flatulence—Epirubicin—ovarian cancer	0.000141	0.000816	CcSEcCtD
Liotrix—Tension—Epirubicin—ovarian cancer	0.00014	0.000813	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—ovarian cancer	0.00014	0.000811	CcSEcCtD
Liotrix—Diarrhoea—Paclitaxel—ovarian cancer	0.00014	0.000809	CcSEcCtD
Liotrix—Nervousness—Epirubicin—ovarian cancer	0.000139	0.000805	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—ovarian cancer	0.000137	0.000792	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—ovarian cancer	0.000137	0.000792	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—ovarian cancer	0.000136	0.000787	CcSEcCtD
Liotrix—Dizziness—Paclitaxel—ovarian cancer	0.000135	0.000782	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—ovarian cancer	0.000135	0.000781	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—ovarian cancer	0.000134	0.000778	CcSEcCtD
Liotrix—Agitation—Epirubicin—ovarian cancer	0.000131	0.000761	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—ovarian cancer	0.00013	0.000755	CcSEcCtD
Liotrix—Tension—Doxorubicin—ovarian cancer	0.00013	0.000752	CcSEcCtD
Liotrix—Vomiting—Paclitaxel—ovarian cancer	0.00013	0.000752	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—ovarian cancer	0.000129	0.000751	CcSEcCtD
Liotrix—Rash—Paclitaxel—ovarian cancer	0.000129	0.000746	CcSEcCtD
Liotrix—Dermatitis—Paclitaxel—ovarian cancer	0.000128	0.000745	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—ovarian cancer	0.000128	0.000745	CcSEcCtD
Liotrix—Syncope—Epirubicin—ovarian cancer	0.000128	0.000743	CcSEcCtD
Liotrix—Headache—Paclitaxel—ovarian cancer	0.000128	0.000741	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—ovarian cancer	0.000127	0.000739	CcSEcCtD
Liotrix—Palpitations—Epirubicin—ovarian cancer	0.000126	0.000732	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—ovarian cancer	0.000126	0.000728	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—ovarian cancer	0.000125	0.000722	CcSEcCtD
Liotrix—Asthenia—Docetaxel—ovarian cancer	0.000124	0.000719	CcSEcCtD
Liotrix—Convulsion—Epirubicin—ovarian cancer	0.000124	0.000718	CcSEcCtD
Liotrix—Hypertension—Epirubicin—ovarian cancer	0.000123	0.000715	CcSEcCtD
Liotrix—Pruritus—Docetaxel—ovarian cancer	0.000122	0.000709	CcSEcCtD
Liotrix—Chest pain—Epirubicin—ovarian cancer	0.000122	0.000705	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—ovarian cancer	0.000122	0.000705	CcSEcCtD
Liotrix—Agitation—Doxorubicin—ovarian cancer	0.000121	0.000704	CcSEcCtD
Liotrix—Anxiety—Epirubicin—ovarian cancer	0.000121	0.000703	CcSEcCtD
Liotrix—Nausea—Paclitaxel—ovarian cancer	0.000121	0.000703	CcSEcCtD
Liotrix—Syncope—Doxorubicin—ovarian cancer	0.000119	0.000687	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—ovarian cancer	0.000118	0.000686	CcSEcCtD
Liotrix—Confusional state—Epirubicin—ovarian cancer	0.000118	0.000682	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—ovarian cancer	0.000117	0.000677	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—ovarian cancer	0.000117	0.000676	CcSEcCtD
Liotrix—Oedema—Epirubicin—ovarian cancer	0.000117	0.000676	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—ovarian cancer	0.000116	0.000674	CcSEcCtD
Liotrix—Infection—Epirubicin—ovarian cancer	0.000116	0.000672	CcSEcCtD
Liotrix—Shock—Epirubicin—ovarian cancer	0.000115	0.000665	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—ovarian cancer	0.000115	0.000664	CcSEcCtD
Liotrix—Dizziness—Docetaxel—ovarian cancer	0.000114	0.000663	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—ovarian cancer	0.000114	0.000662	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—ovarian cancer	0.000114	0.00066	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—ovarian cancer	0.000113	0.000654	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—ovarian cancer	0.000113	0.000653	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—ovarian cancer	0.000113	0.000653	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—ovarian cancer	0.000112	0.00065	CcSEcCtD
Liotrix—Anorexia—Epirubicin—ovarian cancer	0.000111	0.000645	CcSEcCtD
Liotrix—Vomiting—Docetaxel—ovarian cancer	0.00011	0.000637	CcSEcCtD
Liotrix—Rash—Docetaxel—ovarian cancer	0.000109	0.000632	CcSEcCtD
Liotrix—Hypotension—Epirubicin—ovarian cancer	0.000109	0.000632	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—ovarian cancer	0.000109	0.000632	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—ovarian cancer	0.000109	0.000631	CcSEcCtD
Liotrix—Headache—Docetaxel—ovarian cancer	0.000108	0.000628	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000108	0.000626	CcSEcCtD
Liotrix—Oedema—Doxorubicin—ovarian cancer	0.000108	0.000626	CcSEcCtD
Liotrix—Infection—Doxorubicin—ovarian cancer	0.000107	0.000622	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000106	0.000616	CcSEcCtD
Liotrix—Shock—Doxorubicin—ovarian cancer	0.000106	0.000616	CcSEcCtD
Liotrix—Insomnia—Epirubicin—ovarian cancer	0.000105	0.000612	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—ovarian cancer	0.000105	0.000611	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—ovarian cancer	0.000105	0.000607	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000104	0.000605	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—ovarian cancer	0.000104	0.000603	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—ovarian cancer	0.000103	0.000596	CcSEcCtD
Liotrix—Nausea—Docetaxel—ovarian cancer	0.000103	0.000595	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—ovarian cancer	0.000101	0.000588	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—ovarian cancer	0.000101	0.000585	CcSEcCtD
Liotrix—Fatigue—Epirubicin—ovarian cancer	0.000101	0.000583	CcSEcCtD
Liotrix—Constipation—Epirubicin—ovarian cancer	9.97e-05	0.000578	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.83e-05	0.00057	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—ovarian cancer	9.76e-05	0.000566	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—ovarian cancer	9.69e-05	0.000562	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—ovarian cancer	9.62e-05	0.000558	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—ovarian cancer	9.61e-05	0.000557	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—ovarian cancer	9.54e-05	0.000553	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—ovarian cancer	9.38e-05	0.000544	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—ovarian cancer	9.3e-05	0.000539	CcSEcCtD
Liotrix—Urticaria—Epirubicin—ovarian cancer	9.26e-05	0.000537	CcSEcCtD
Liotrix—Constipation—Doxorubicin—ovarian cancer	9.23e-05	0.000535	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—ovarian cancer	9.22e-05	0.000535	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—ovarian cancer	9.22e-05	0.000535	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—ovarian cancer	8.89e-05	0.000516	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.82e-05	0.000512	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—ovarian cancer	8.59e-05	0.000498	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—ovarian cancer	8.57e-05	0.000497	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—ovarian cancer	8.53e-05	0.000495	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—ovarian cancer	8.53e-05	0.000495	CcSEcCtD
Liotrix—Asthenia—Epirubicin—ovarian cancer	8.37e-05	0.000485	CcSEcCtD
Liotrix—Pruritus—Epirubicin—ovarian cancer	8.25e-05	0.000478	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—ovarian cancer	7.98e-05	0.000463	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—ovarian cancer	7.95e-05	0.000461	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—ovarian cancer	7.74e-05	0.000449	CcSEcCtD
Liotrix—Dizziness—Epirubicin—ovarian cancer	7.71e-05	0.000447	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—ovarian cancer	7.63e-05	0.000443	CcSEcCtD
Liotrix—Vomiting—Epirubicin—ovarian cancer	7.41e-05	0.00043	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—ovarian cancer	7.38e-05	0.000428	CcSEcCtD
Liotrix—Rash—Epirubicin—ovarian cancer	7.35e-05	0.000426	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—ovarian cancer	7.35e-05	0.000426	CcSEcCtD
Liotrix—Headache—Epirubicin—ovarian cancer	7.31e-05	0.000424	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—ovarian cancer	7.14e-05	0.000414	CcSEcCtD
Liotrix—Nausea—Epirubicin—ovarian cancer	6.93e-05	0.000402	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—ovarian cancer	6.86e-05	0.000398	CcSEcCtD
Liotrix—Rash—Doxorubicin—ovarian cancer	6.8e-05	0.000394	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—ovarian cancer	6.8e-05	0.000394	CcSEcCtD
Liotrix—Headache—Doxorubicin—ovarian cancer	6.76e-05	0.000392	CcSEcCtD
Liotrix—Nausea—Doxorubicin—ovarian cancer	6.41e-05	0.000372	CcSEcCtD
Liotrix—TTR—Signaling Pathways—PPP2R1A—ovarian cancer	2.82e-05	0.00054	CbGpPWpGaD
Liotrix—TTR—Disease—IL6ST—ovarian cancer	2.81e-05	0.000537	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL6—ovarian cancer	2.79e-05	0.000534	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.78e-05	0.000532	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.76e-05	0.000528	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.75e-05	0.000526	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.74e-05	0.000524	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SPARC—ovarian cancer	2.74e-05	0.000523	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.73e-05	0.000523	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.71e-05	0.000518	CbGpPWpGaD
Liotrix—TTR—Disease—APC—ovarian cancer	2.7e-05	0.000516	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.68e-05	0.000512	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—FASN—ovarian cancer	2.59e-05	0.000495	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.57e-05	0.000491	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	2.54e-05	0.000487	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.53e-05	0.000484	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—YAP1—ovarian cancer	2.49e-05	0.000477	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.47e-05	0.000472	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	2.46e-05	0.00047	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CAV1—ovarian cancer	2.45e-05	0.000469	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.41e-05	0.00046	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CD—ovarian cancer	2.37e-05	0.000453	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	2.36e-05	0.000451	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.34e-05	0.000448	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.32e-05	0.000443	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MAPK3—ovarian cancer	2.31e-05	0.000441	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MAPK3—ovarian cancer	2.31e-05	0.000441	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.26e-05	0.000432	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	2.26e-05	0.000432	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MYC—ovarian cancer	2.24e-05	0.000429	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MYC—ovarian cancer	2.24e-05	0.000429	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.24e-05	0.000429	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TERT—ovarian cancer	2.24e-05	0.000429	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CG—ovarian cancer	2.23e-05	0.000427	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.23e-05	0.000426	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	2.22e-05	0.000424	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.17e-05	0.000415	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—YAP1—ovarian cancer	2.13e-05	0.000408	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.11e-05	0.000403	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB2—ovarian cancer	2.09e-05	0.0004	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYTB—ovarian cancer	2.09e-05	0.0004	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	2.09e-05	0.0004	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.09e-05	0.000399	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.08e-05	0.000398	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYTB—ovarian cancer	2.08e-05	0.000397	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CAV1—ovarian cancer	2.07e-05	0.000396	CbGpPWpGaD
Liotrix—TTR—Disease—MTOR—ovarian cancer	2.07e-05	0.000395	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CB—ovarian cancer	2.07e-05	0.000395	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.04e-05	0.000391	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—FASN—ovarian cancer	2.03e-05	0.000389	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.03e-05	0.000388	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.01e-05	0.000385	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	2e-05	0.000382	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ESR1—ovarian cancer	2e-05	0.000382	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SOD1—ovarian cancer	1.99e-05	0.00038	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.98e-05	0.000378	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.97e-05	0.000376	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6ST—ovarian cancer	1.97e-05	0.000376	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.96e-05	0.000376	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CD—ovarian cancer	1.96e-05	0.000375	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.94e-05	0.000371	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1B—ovarian cancer	1.94e-05	0.000371	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	1.93e-05	0.000369	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.91e-05	0.000364	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.89e-05	0.000362	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CG—ovarian cancer	1.89e-05	0.000361	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—APC—ovarian cancer	1.89e-05	0.000361	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.85e-05	0.000355	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.85e-05	0.000354	CbGpPWpGaD
Liotrix—TTR—Disease—CTNNB1—ovarian cancer	1.83e-05	0.00035	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.83e-05	0.000349	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.83e-05	0.000349	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.83e-05	0.000349	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYTB—ovarian cancer	1.82e-05	0.000348	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.82e-05	0.000348	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPP1CC—ovarian cancer	1.82e-05	0.000347	CbGpPWpGaD
Liotrix—ALB—Metabolism—BRIP1—ovarian cancer	1.82e-05	0.000347	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.81e-05	0.000346	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—ovarian cancer	1.79e-05	0.000341	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.78e-05	0.000341	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.76e-05	0.000337	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—FASN—ovarian cancer	1.74e-05	0.000332	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.73e-05	0.000332	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.72e-05	0.000329	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CB—ovarian cancer	1.71e-05	0.000327	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.71e-05	0.000327	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.67e-05	0.00032	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CD—ovarian cancer	1.66e-05	0.000317	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.65e-05	0.000316	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.64e-05	0.000314	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.63e-05	0.000312	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.62e-05	0.000309	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—ovarian cancer	1.6e-05	0.000305	CbGpPWpGaD
Liotrix—TTR—Disease—NRAS—ovarian cancer	1.59e-05	0.000305	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.59e-05	0.000304	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BRIP1—ovarian cancer	1.59e-05	0.000304	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.59e-05	0.000304	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.58e-05	0.000303	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—ovarian cancer	1.56e-05	0.000297	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—ovarian cancer	1.56e-05	0.000297	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.54e-05	0.000294	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.54e-05	0.000294	CbGpPWpGaD
Liotrix—TTR—Disease—MAPK3—ovarian cancer	1.53e-05	0.000292	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.52e-05	0.000291	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.51e-05	0.000289	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.5e-05	0.000286	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—ovarian cancer	1.48e-05	0.000284	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—ovarian cancer	1.48e-05	0.000283	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.47e-05	0.000281	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—ovarian cancer	1.47e-05	0.00028	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CAV1—ovarian cancer	1.45e-05	0.000278	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.45e-05	0.000278	CbGpPWpGaD
Liotrix—TTR—Disease—MAPK1—ovarian cancer	1.45e-05	0.000278	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—ovarian cancer	1.45e-05	0.000278	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MTOR—ovarian cancer	1.45e-05	0.000277	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CB—ovarian cancer	1.45e-05	0.000277	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.43e-05	0.000274	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.4e-05	0.000268	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.4e-05	0.000267	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.4e-05	0.000267	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.39e-05	0.000266	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—ovarian cancer	1.39e-05	0.000266	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.38e-05	0.000264	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—ovarian cancer	1.37e-05	0.000262	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.36e-05	0.00026	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.36e-05	0.00026	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1B—ovarian cancer	1.36e-05	0.00026	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.33e-05	0.000255	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—ovarian cancer	1.33e-05	0.000255	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—ovarian cancer	1.33e-05	0.000254	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—ovarian cancer	1.32e-05	0.000253	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.32e-05	0.000253	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.3e-05	0.000249	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—ovarian cancer	1.3e-05	0.000248	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.29e-05	0.000246	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—ovarian cancer	1.28e-05	0.000245	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.28e-05	0.000245	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—ovarian cancer	1.26e-05	0.000241	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—ovarian cancer	1.26e-05	0.000241	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—ovarian cancer	1.25e-05	0.000239	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.23e-05	0.000235	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—YAP1—ovarian cancer	1.22e-05	0.000234	CbGpPWpGaD
Liotrix—ALB—Metabolism—YAP1—ovarian cancer	1.22e-05	0.000233	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.21e-05	0.000232	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.21e-05	0.000231	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.21e-05	0.000231	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.2e-05	0.000229	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.18e-05	0.000226	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—ovarian cancer	1.17e-05	0.000223	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—ovarian cancer	1.16e-05	0.000223	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.15e-05	0.00022	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.14e-05	0.000219	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—ovarian cancer	1.13e-05	0.000216	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—ovarian cancer	1.12e-05	0.000214	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—ovarian cancer	1.12e-05	0.000213	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—ovarian cancer	1.12e-05	0.000213	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.1e-05	0.00021	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	1.07e-05	0.000205	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK3—ovarian cancer	1.07e-05	0.000204	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000204	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.07e-05	0.000204	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.06e-05	0.000203	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—ovarian cancer	1.04e-05	0.000199	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—ovarian cancer	1.04e-05	0.000199	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.03e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—ovarian cancer	1.03e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK1—ovarian cancer	1.02e-05	0.000194	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—ovarian cancer	1.02e-05	0.000194	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—ovarian cancer	1.01e-05	0.000194	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—FASN—ovarian cancer	9.99e-06	0.000191	CbGpPWpGaD
Liotrix—ALB—Metabolism—FASN—ovarian cancer	9.93e-06	0.00019	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.85e-06	0.000188	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC5A5—ovarian cancer	9.82e-06	0.000188	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	9.8e-06	0.000187	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC5A5—ovarian cancer	9.77e-06	0.000187	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	9.66e-06	0.000185	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.65e-06	0.000185	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—ovarian cancer	9.6e-06	0.000184	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC2A1—ovarian cancer	9.49e-06	0.000181	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC2A1—ovarian cancer	9.43e-06	0.00018	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	9.39e-06	0.00018	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—ovarian cancer	9.32e-06	0.000178	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.29e-06	0.000178	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—ovarian cancer	9.26e-06	0.000177	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.24e-06	0.000177	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1B1—ovarian cancer	9.09e-06	0.000174	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1B1—ovarian cancer	9.04e-06	0.000173	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—ovarian cancer	8.82e-06	0.000169	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—FASN—ovarian cancer	8.7e-06	0.000166	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.56e-06	0.000164	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—ovarian cancer	8.53e-06	0.000163	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—ovarian cancer	8.52e-06	0.000163	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	8.42e-06	0.000161	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.26e-06	0.000158	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	8.26e-06	0.000158	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—ovarian cancer	8.16e-06	0.000156	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	8.07e-06	0.000154	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.03e-06	0.000154	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPP2R1A—ovarian cancer	8.02e-06	0.000153	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.98e-06	0.000153	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.92e-06	0.000152	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—ovarian cancer	7.92e-06	0.000151	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—ovarian cancer	7.82e-06	0.00015	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—ovarian cancer	7.81e-06	0.000149	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK3—ovarian cancer	7.49e-06	0.000143	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—ovarian cancer	7.49e-06	0.000143	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—ovarian cancer	7.45e-06	0.000142	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—ovarian cancer	7.36e-06	0.000141	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—ovarian cancer	7.31e-06	0.00014	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—ovarian cancer	7.27e-06	0.000139	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—ovarian cancer	7.21e-06	0.000138	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	7.2e-06	0.000138	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK1—ovarian cancer	7.13e-06	0.000136	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPP2R1A—ovarian cancer	7.03e-06	0.000134	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—ovarian cancer	6.73e-06	0.000129	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	6.53e-06	0.000125	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—ovarian cancer	6.41e-06	0.000123	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—ovarian cancer	6.22e-06	0.000119	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—ovarian cancer	6.18e-06	0.000118	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—ovarian cancer	5.98e-06	0.000114	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAV1—ovarian cancer	5.93e-06	0.000113	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAV1—ovarian cancer	5.89e-06	0.000113	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—ovarian cancer	5.72e-06	0.000109	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.66e-06	0.000108	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.63e-06	0.000108	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.4e-06	0.000103	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—ovarian cancer	5.37e-06	0.000103	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—ovarian cancer	5.34e-06	0.000102	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAV1—ovarian cancer	5.16e-06	9.88e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	5.13e-06	9.81e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—ovarian cancer	5.05e-06	9.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.75e-06	9.08e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—ovarian cancer	4.72e-06	9.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.7e-06	9e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.39e-06	8.39e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—ovarian cancer	4.19e-06	8.02e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.14e-06	7.91e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.13e-06	7.91e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—ovarian cancer	4.11e-06	7.87e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.6e-06	6.89e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.59e-06	6.86e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—ovarian cancer	3.57e-06	6.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—ovarian cancer	3.55e-06	6.8e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—ovarian cancer	3.11e-06	5.96e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.52e-06	4.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—ovarian cancer	2.51e-06	4.8e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.2e-06	4.2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—ovarian cancer	2.06e-06	3.94e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—ovarian cancer	2.05e-06	3.92e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—ovarian cancer	1.79e-06	3.43e-05	CbGpPWpGaD
